MDAI

From DMT-Nexus Wiki
Revision as of 22:23, 19 December 2013 by Hixidom (talk | contribs)
Jump to navigationJump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Safety profile
Category:
  • Entactogen, Empathogen, SSRA
Main effects:
  • Entactogenic effects, Empathogenic effects, Euphoria
Side effects:
  • Nausea, headache, tiredness, depression, rise in blood pressure
Health risks:
  • Mental addiction. WARNING: Some studies have shown that much of what is sold online as "MDAI" actually contains other drugs such as mephedrone.
Important safety remarks:
  • Cardiovascular toxicity has not been tested. As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!


Brief overview - What is MDAI?

5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA). Like MDA and MDMA, it produces entactogenic effects but, unlike similar drugs, it results in little to no stimulant effects.